Ligan, Richzia .

HRN: 21-05-94  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/17/2022
CEFUROXIME 750MG (VIAL)
07/17/2022
07/23/2022
IV
220mg
Q8Hrs
PCAP-C
Waiting Final Action 
10/02/2022
AMPICILLIN 1GM (VIAL)
10/02/2022
10/07/2022
IVT
200mg
Q6
Pcap C
Waiting Final Action 
01/10/2023
CEFTRIAXONE 1G (VIAL)
01/10/2023
01/17/2023
IVT
400mg
Q12
PCAP
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: